These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 22196910)

  • 1. MRSA new treatments on the horizon: current status.
    Wilcox MH
    Injury; 2011 Dec; 42 Suppl 5():S42-4. PubMed ID: 22196910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New antibiotics in the management of acute bacterial skin and skin structure infections.
    Gleghorn K; Grimshaw E; Kelly EK
    Skin Therapy Lett; 2015; 20(5):7-9. PubMed ID: 26382907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New antimicrobial agents for methicillin-resistant Staphylococcus aureus.
    Kollef MH
    Crit Care Resusc; 2009 Dec; 11(4):282-6. PubMed ID: 20001879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New antibiotics for healthcare-associated pneumonia.
    Neuner EA; Ritchie DJ; Micek ST
    Semin Respir Crit Care Med; 2009 Feb; 30(1):92-101. PubMed ID: 19199191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid.
    Stein GE; Wells EM
    Curr Med Res Opin; 2010 Mar; 26(3):571-88. PubMed ID: 20055750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The problem of complicated skin and skin structure infections: the need for new agents.
    Moellering RC
    J Antimicrob Chemother; 2010 Nov; 65 Suppl 4():iv3-8. PubMed ID: 21115452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.
    Corey GR; Wilcox MH; Talbot GH; Thye D; Friedland D; Baculik T;
    J Antimicrob Chemother; 2010 Nov; 65 Suppl 4():iv41-51. PubMed ID: 21115454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on prevalence and treatment of methicillin-resistant Staphylococcus aureus infections.
    Loffler CA; Macdougall C
    Expert Rev Anti Infect Ther; 2007 Dec; 5(6):961-81. PubMed ID: 18039081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.
    Wilcox MH; Corey GR; Talbot GH; Thye D; Friedland D; Baculik T;
    J Antimicrob Chemother; 2010 Nov; 65 Suppl 4():iv53-iv65. PubMed ID: 21115455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and therapeutic evaluation of community-acquired methicillin-resistant Staphylococcus Aureus (MRSA) skin and soft tissue infections in the emergency department.
    Walraven CJ; Lingenfelter E; Rollo J; Madsen T; Alexander DP
    J Emerg Med; 2012 Apr; 42(4):392-9. PubMed ID: 21524884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamics of ceftaroline fosamil for complicated skin and skin structure infection: rationale for improved anti-methicillin-resistant Staphylococcus aureus activity.
    Drusano GL
    J Antimicrob Chemother; 2010 Nov; 65 Suppl 4():iv33-9. PubMed ID: 21115453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pan-European early switch/early discharge opportunities exist for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections.
    Nathwani D; Eckmann C; Lawson W; Stephens JM; Macahilig C; Solem CT; Simoneau D; Chambers R; Li JZ; Haider S
    Clin Microbiol Infect; 2014 Oct; 20(10):993-1000. PubMed ID: 24673973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus.
    Elliott DJ; Zaoutis TE; Troxel AB; Loh A; Keren R
    Pediatrics; 2009 Jun; 123(6):e959-66. PubMed ID: 19470525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effectiveness of antibiotics for the treatment of MRSA complicated skin and soft tissue infections.
    Logman JF; Stephens J; Heeg B; Haider S; Cappelleri J; Nathwani D; Tice A; van Hout BA
    Curr Med Res Opin; 2010 Jul; 26(7):1565-78. PubMed ID: 20429820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic antibiotic treatment of skin, skin structure, and soft tissue infections in the outpatient setting.
    Jones H
    Adv Skin Wound Care; 2012 Mar; 25(3):132-40; quiz 141-2. PubMed ID: 22343601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective case-control analysis of patients with staphylococcal infections receiving daptomycin or glycopeptide therapy.
    Falcone M; Russo A; Pompeo ME; Vena A; Marruncheddu L; Ciccaglioni A; Grossi P; Mancini C; Novelli A; Stefani S; Venditti M
    Int J Antimicrob Agents; 2012 Jan; 39(1):64-8. PubMed ID: 22047703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should the methicillin-resistant Staphylococcus aureus carriage status be used as a guide to treatment for skin and soft tissue infections?
    Reber A; Moldovan A; Dunkel N; Emonet S; Rohner P; Tahintzi P; Hoffmeyer P; Harbarth S; Uçkay I
    J Infect; 2012 May; 64(5):513-9. PubMed ID: 22327191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging issues in the diagnosis and management of infections caused by multi-drug-resistant, gram-positive cocci.
    Napolitano LM
    Surg Infect (Larchmt); 2005; 6 Suppl 2():S-5-22. PubMed ID: 23577494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging drugs for complicated skin and skin-structure infections.
    Mendoza N; Tyring SK
    Expert Opin Emerg Drugs; 2010 Sep; 15(3):509-20. PubMed ID: 20557269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections.
    Russo A; Concia E; Cristini F; De Rosa FG; Esposito S; Menichetti F; Petrosillo N; Tumbarello M; Venditti M; Viale P; Viscoli C; Bassetti M
    Clin Microbiol Infect; 2016 Apr; 22 Suppl 2():S27-36. PubMed ID: 27125562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.